Number of Shares
451.00
Current Holdings Value*
$28,780.00
% of Portfolio
0.33%
Total Estimate Gain
$18,558.52
% of Total Estimate Gain
47.99%

PROFUND VP ULTRA SMALL CAP's Halozyme Therapeutics Inc Holding Summary

As of 2025-03-31, PROFUND VP ULTRA SMALL CAP held 451.00 shares of Halozyme Therapeutics Inc(HALO), totaling $28,780.00. This investment constitutes 0.33% of their stock portfolio, and PROFUND VP ULTRA SMALL CAP now holds 0% of the outstanding Halozyme Therapeutics Inc(HALO) stock.

The initial trade took place in 2019Q3. And since then PROFUND VP ULTRA SMALL CAP has made 9 purchases of HALO, at an average price of $25.16, for a total of 1,537.00 shares. In addition, there have been 11 sales at an average price of $29.25 for 1,086.00 shares. Based on historical transaction data and HALO's current price of $56.45, PROFUND VP ULTRA SMALL CAP's estimated gain on his HALO holdings is $18,558.52, reflecting a 47.99% gain to date.

PROFUND VP ULTRA SMALL CAP HALO ($56.45) Holding Chart

PROFUND VP ULTRA SMALL CAP HALO ($56.45) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1